Ming Tan

Cincinnati Children's Hospital Medical Center — United States

Medicine · Health Sciences

45h-index7.3kcitations148works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral gastroenteritis research and epidemiology(122), Animal Virus Infections Studies(69), Viral Infections and Immunology Research(61), Virus-based gene therapy research(42), Respiratory viral infections research(19)

Publications148 total

Avian Immunoglobulin Y Antibodies Targeting the Protruding or Shell Domain of Norovirus Capsid Protein Neutralize Norovirus Replication in the Human Intestinal Enteroid System
Vaccines·2025Open Access
The Impact of Norovirus on Children and Adolescents: Implications for Ongoing Vaccine Development
Current Pediatrics Reports·2025Open Access
A Nanoparticle Comprising the Receptor-Binding Domains of Norovirus and Plasmodium as a Combination Vaccine Candidate
Vaccines·2025Open Access
Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus challenges
Vaccine·2024· 1 citedOpen Access
Prevalence and genotype distribution of norovirus in Ningxia Hui Autonomous Region, China, from 2011 to 2022
Virology Journal·2024· 4 citedOpen Access
A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge
Vaccines·2024· 2 citedOpen Access
A Viral Protein 4-Based Trivalent Nanoparticle Vaccine Elicited High and Broad Immune Responses and Protective Immunity against the Predominant Rotaviruses
ACS Nano·2024· 8 cited
Pseudovirus Nanoparticles Displaying Plasmodium Circumsporozoite Proteins Elicited High Titers of Sporozoite-Binding Antibody
Vaccines·2023· 3 citedOpen Access
Norovirus outbreaks in hospitals in China: a systematic review
Journal of Hospital Infection·2023· 4 cited
A bioengineered pseudovirus nanoparticle displaying SARS‐CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS‐CoV 2 challenge
Biotechnology Journal·2023· 6 citedOpen Access
The αTSR Domain of Plasmodium Circumsporozoite Protein Bound Heparan Sulfates and Elicited High Titers of Sporozoite Binding Antibody After Displayed by Nanoparticles
International Journal of Nanomedicine·2023· 6 citedOpen Access
Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix® and a Nanoparticle-Based Trivalent Rotavirus Vaccine Evaluated in Gnotobiotic Pig Models of G4P[6] and G1P[8] Human Rotavirus Infection
Vaccines·2023· 4 citedOpen Access
Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses
Proceedings of the National Academy of Sciences·2023· 22 citedOpen Access
Structural basis of host ligand specificity change of GII porcine noroviruses from their closely related GII human noroviruses
Figshare·2023Open Access
A New Gnotobiotic Pig Model of P[6] Human Rotavirus Infection and Disease for Preclinical Evaluation of Rotavirus Vaccines
Viruses·2022· 7 citedOpen Access
The Association between Symptomatic Rotavirus Infection and Histo-Blood Group Antigens in Young Children with Diarrhea in Pretoria, South Africa
Viruses·2022· 4 citedOpen Access
Mucosal and systemic neutralizing antibodies to norovirus and rotavirus by oral immunization with recombinant rotavirus in infant mice
2022· 2 citedOpen Access
A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response
Pharmaceutics·2022· 14 citedOpen Access
Bovine natural antibody <scp>IgM</scp> inhibits the binding of human norovirus protruding domain to its <scp>HBGA</scp> receptors
FEBS Open Bio·2022· 1 citedOpen Access
Structural Insight into Terminal Galactose Recognition by Two Non-HBGA Binding GI.3 Noroviruses
Journal of Virology·2022· 2 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Xi Jiang(47), Ming Xia(20), Pengwei Huang(16), Weiming Zhong(15), Jarek Meller(7), Yang Liu(5), Tibor Farkas(4), Ardythe L. Morrow(4), Yutao Chen(4), Zihe Rao(4), Rashmi S. Hegde(4), Leyi Wang(4), Wen Jiang(4), Miao Jin(4), Zhaojun Duan(4), Xu-Fu Zhang(4), Ying‐Chun Dai(4), Chao Wei(3), Ping‐An Fang(3), Monica McNeal(3)